A phase I study of combined trabectedin and pegylated liposomal doxorubicin therapy for advanced relapsed ovarian cancer.

Shunji TakahashiMunetaka TakekumaKenji TamuraKazuhiro TakeharaHiroyuki NomuraMakiko OnoMayu YunokawaDaisuke Aoki

Published in: International journal of clinical oncology (2021)

JapicCTI-163164.